Professional Special Situation Investor, TripleS Special Situation Investing

Triple S Special Situations Investing

Professional Special Situation Investor

TripleS Special Situation Investing

Professional Special Situation Investor with over 20 years of experience.

Thematic (Sector/Industry)

<ul><li>I mentioned this liquidation as one to watch a few months ago.</li><li>The board had just approved a plan of liquidation and guided to $29.73 to $37.69 a share of total distributions.</li><li>Shareholders approved the liquidation in June.</li></ul>

I mentioned this liquidation as one to watch a few months ago.The board had just approved a plan of liquidation and guided to $29.73 to $37.69 a share of total distributions.Shareholders approved the liquidation in June.

3 Mergers and 1 Liquidation in the Danger Zone

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>I tally 50 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.</li>
<li>Three new deals discussed this week: <a href="https://www.smartkarma.com/entities/fancl-corp" target="_blank" data-smartkarma-citation="entities:15862:1" rel="noopener">Fancl (4921 JP)</a>'s Tender offer, <a href="https://www.smartkarma.com/entities/a8-new-media-group-ltd" target="_blank" data-smartkarma-citation="entities:3444:1" rel="noopener">A8 New Media (800 HK)</a>'s Scheme, and <a href="https://www.smartkarma.com/entities/jeisys-medical-inc" target="_blank" data-smartkarma-citation="entities:36766:1" rel="noopener">Jeisys Medical (287410 KS)</a>'s delisting offer. Bain also approached <a href="https://www.smartkarma.com/entities/bapcor-ltd" target="_blank" data-smartkarma-citation="entities:8433:1" rel="noopener">Bapcor (BAP AU)</a>.</li>
<li>Key updates took place on: <a href="https://www.smartkarma.com/entities/sigma-healthcare-ltd" target="_blank" data-smartkarma-citation="entities:15966:1" rel="noopener">Sigma Healthcare (SIG AU)</a>, <a href="https://www.smartkarma.com/entities/alumina-ltd" target="_blank" data-smartkarma-citation="entities:939:1" rel="noopener">Alumina (AWC AU)</a>, <a href="https://www.smartkarma.com/entities/greatview-aseptic-packaging" target="_blank" data-smartkarma-citation="entities:10802:1" rel="noopener">Greatview Aseptic Packaging (468 HK)</a>, <a href="https://www.smartkarma.com/entities/helios-techno-holding-co-ltd" target="_blank" data-smartkarma-citation="entities:13934:1" rel="noopener">Helios Techno (6927 JP)</a>, and <a href="https://www.smartkarma.com/entities/tatsuta-electric-wire-cable-co-ltd" target="_blank" data-smartkarma-citation="entities:12509:1" rel="noopener">Tatsuta Electric Wire &amp; Cable (5809 JP)</a>.</li>
</ul>


I tally 50 - mostly firm, mostly Asia-Pac - transactions currently being discussed and analysed on Smartkarma. Inside is a timetable of upcoming key events for each deal.
Three new deals discussed this week: Fancl (4921 JP)'s Tender offer, A8 New Media (800 HK)'s Scheme, and Jeisys Medical (287410 KS)'s delisting offer. Bain also approached Bapcor (BAP AU).
Key updates took place on: Sigma Healthcare (SIG AU), Alumina (AWC AU), Greatview Aseptic Packaging (468 HK), Helios Techno (6927 JP), and Tatsuta Electric Wire &amp; Cable (5809 JP).


(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

<ul>
<li>Back in November 2023, African-Focused lithium play <a href="https://www.smartkarma.com/entities/atlantic-lithium-ltd" target="_blank" data-smartkarma-citation="entities:40322:1" rel="noopener">Atlantic Lithium (A11 AU)</a> announced it had twice rejected NBIOs from South African-based Assore International, its major shareholder. </li>
<li>Assore offered A$0.63/share by way of Scheme, a 64% premium to undisturbed. Atlantic's IBC rejected terms as they were not in the best interest of shareholders. </li>
<li>Atlantic has now entered a Scheme with <a href="https://www.smartkarma.com/entities/zhejiang-huayou-cobalt-co-ltd" target="_blank" data-smartkarma-citation="entities:25048:1" rel="noopener">Zhejiang Huayou Cobalt (603799 CH)</a>. Price? A$0.354/share, a 26.6% premium to undisturbed. Assore, holding 26.4%, and directors (1.8%), are supportive. This is done. </li>
</ul>


Back in November 2023, African-Focused lithium play Atlantic Lithium (A11 AU) announced it had twice rejected NBIOs from South African-based Assore International, its major shareholder. 
Assore offered A$0.63/share by way of Scheme, a 64% premium to undisturbed. Atlantic's IBC rejected terms as they were not in the best interest of shareholders. 
Atlantic has now entered a Scheme with Zhejiang Huayou Cobalt (603799 CH). Price? A$0.354/share, a 26.6% premium to undisturbed. Assore, holding 26.4%, and directors (1.8%), are supportive. This is done. 


Atlantic Lithium (A11 AU) Enters Scheme With Zhejiang Huayou Cobalt

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/atlantic-lithium-ltd" target="_blank" data-smartkarma-citation="entities:40322:1" rel="noopener">Atlantic Lithium (A11 AU)</a> entered a scheme implementation deed with <a href="https://www.smartkarma.com/entities/zhejiang-huayou-cobalt-co-ltd" target="_blank" data-smartkarma-citation="entities:25048:1" rel="noopener">Zhejiang Huayou Cobalt (603799 CH)</a> at US$0.25486 per share (A$0.354 per share), a 26.6% premium to the undisturbed price. </li>
<li>The offer is light as it is below the three-month high and 43.7% below Assore’s rejected NBIO of A$0.63 on 15 November 2023.</li>
<li>Nevertheless, the scheme vote is low risk due to Assore’s irrevocable undertaking, a supportive shareholder structure, and moderate retail ownership. Regulatory approvals should also be forthcoming.    </li>
</ul>



Atlantic Lithium (A11 AU) entered a scheme implementation deed with Zhejiang Huayou Cobalt (603799 CH) at US$0.25486 per share (A$0.354 per share), a 26.6% premium to the undisturbed price. 
The offer is light as it is below the three-month high and 43.7% below Assore’s rejected NBIO of A$0.63 on 15 November 2023.
Nevertheless, the scheme vote is low risk due to Assore’s irrevocable undertaking, a supportive shareholder structure, and moderate retail ownership. Regulatory approvals should also be forthcoming.    


Atlantic Lithium (A11 AU): Huayou Cobalt’s Binding Proposal Is Light but Likely Done

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
 <li>
<a href="https://smartkarma.com/entities/atlantic-lithium-ltd">Atlantic Lithium </a>is poised to become Ghana's first lithium producer with its flagship Ewoyaa project, which is now significantly de-risked following the ratification of its Mining Lease by the Ghanaian Parliament in March 2026.</li>
 <li>The Ewoyaa project is underpinned by a robust Definitive Feasibility Study (DFS) showcasing a 36.8Mt Mineral Resource Estimate at 1.24% Li₂O, with a projected 12-year mine life and total production of 3.6 million tonnes of spodumene concentrate.</li>
 <li>Strategic funding and offtake agreements are in place with Elevra Lithium, and the company has recently secured additional funding, including from Ghanaian institutional investors, demonstrating strong in-country support and a clear path to a Final Investment Decision.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Atlantic Lithium is poised to become Ghana's first lithium producer with its flagship Ewoyaa project, which is now significantly de-risked following the ratification of its Mining Lease by the Ghanaian Parliament in March 2026.
  The Ewoyaa project is underpinned by a robust Definitive Feasibility Study (DFS) showcasing a 36.8Mt Mineral Resource Estimate at 1.24% Li₂O, with a projected 12-year mine life and total production of 3.6 million tonnes of spodumene concentrate.
  Strategic funding and offtake agreements are in place with Elevra Lithium, and the company has recently secured additional funding, including from Ghanaian institutional investors, demonstrating strong in-country support and a clear path to a Final Investment Decision.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Atlantic Lithium  (A11 AU) - May 2026

Australia

Atlantic Lithium Limited operates as a mining company. The Company focuses on lithium exploration and development to support the global transition to a carbon neutral future.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Atlantic Lithium (A11 AU)

3 Mergers and 1 Liquidation in the Danger Zone

The board had just approved a plan of liquidation and guided to $29.73 to $37.69 a share of total distributions.Shareholders approved the...

Triple S Special Situations Investing

(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

David Blennerhassett